Page-4 of COVAXIN
India: Expert panel recommends approval to Sputnik V vaccine
An Expert panel of the Central Drugs Standard Control Organisation (CDSCO) recently approved the Emergency Use of COVID-19 vaccine Sputnik-V. However, the Drugs Controller General of India (DGCI) is to take a final call on the recommendation. When approved, Sputnik ..
Month: Current Affairs - April, 2021
Tika Utsav: COVID-19 Vaccination Drive
The Prime Minister Narendra Modi recently appealed to the Chief Ministers of the States to organise “Tika Utsav”. What is Tika Utsav? Tika Utsav is a vaccine festival. It is to be held between April 11, 2021 and April 14, ..
Month: Current Affairs - April, 2021
India approved two COVID-19 vaccines for Emergency Use
The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved by DGCI for emergency use? COVAXIN and COVISHIELD What is COVAXIN? The ..
Month: Current Affairs - January, 2021
SII’s Covishield gets emergency-use nod from DGCI
The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute of India. Who manufactures COVISHIELD? The COVISHIELD the vaccine is developed by ..
Month: Current Affairs - January, 2021
COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India
On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to be held in partnership with the Indian Council of Medical Research. The ..
Month: Current Affairs - November, 2020
Mission COVID Suraksha: Key Facts
On November 12, 2020, the Finance Minister Nirmala Sitharaman announced Mission COVID Suraksha. Under the mission, the Government of India has allocated Rs 900 crores to the research and development of COVID-19 vaccines in India. The funds allocated do not ..